Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries
Resource Type
Article
Authors
Barylnik, Julia ; Birdeanu, Laura ; Bosch, Gert P ; Boychevskaya, Julia ; Boyev, Igor ; Bugán, Enikõ ; Bukhanovskaya, Olga ; Chaban, Oleg ; Dobrescu, Iuliana ; Feller, Gábor ; Flisiak-Antonijczuk, Halina ; Gácser, Magdolna ; Grigorieva, Elena ; Holttinen, Timo ; Ivanovic-Kovacevic, Svetlana ; Kapornai, Krisztina ; Kasimova, Lala ; Koren, Evgeniy ; Martsenkovsky, Igor ; Maruta, Nataliya O ; Matican, Mirela ; Matkovska, Tetiana ; Melnyk, Ellina ; Milovancevic, Milica Pejovic ; Mostova, Olha ; Nagy, Peter ; Nussbaum, Laura ; Petrov, Petar ; Pietraszczyk-Kedziora, Bozena ; Polnareva, Nadia ; Predescu, Elena ; Razsolkova, Vladislava ; Rybakowski, Filip ; Rymsha, Sofiia ; Schrönen, Juan P ; Shigashov, Dmitrii ; Skrypnikov, Andrii ; Stankovic, Miodrag ; Stevanovic, Dejan ; Timonen, Markku ; Väänänen, Juha-Matti ; van der Westhuizen, Jannie ; van Niekerk, Gert ; Venger, Olena ; Voloshchuk, Anatolii ; Wolañczyk, Tomasz ; Arango, Celso ; Buitelaar, Jan K ; Fegert, Jörg M ; Olivier, Valérie ; Pénélaud, Pierre-François ; Marx, Ute ; Chimits, Damien ; Falissard, Bruno
Source
In The Lancet Psychiatry February 2022 9(2):113-124
Subject
Primary Research Articles
Language
ISSN
2215-0366